Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Protein kinase C theta type | ||
Ligand | BDBM50517655 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1869435 (CHEMBL4370501) | ||
IC50 | 3.0±n/a nM | ||
Citation | Kunikawa, S; Tanaka, A; Takasuna, Y; Tasaki, M; Chida, N Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions. Bioorg Med Chem27:790-799 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Protein kinase C theta type | |||
Name: | Protein kinase C theta type | ||
Synonyms: | KPCT_HUMAN | PRKCQ | PRKCT | Protein kinase C theta | Protein kinase C theta type (PRKCQ) | Protein kinase C, PKC; classical/novel | nPKC-theta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 81878.04 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Full-length human PKC theta (Panvera Catalog No. P2996). | ||
Residue: | 706 | ||
Sequence: |
| ||
BDBM50517655 | |||
n/a | |||
Name | BDBM50517655 | ||
Synonyms: | CHEMBL4547465 | ||
Type | Small organic molecule | ||
Emp. Form. | C32H45N7OS | ||
Mol. Mass. | 575.811 | ||
SMILES | CC(C)Sc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1 |r,wU:33.35,wD:30.31,TLB:38:37:26:24.23.22,THB:38:23:27.37.39:26,22:23:27:39.21.26,22:21:27:24.38.23,28:27:26:24.23.22,(65.38,-20.16,;64.05,-19.4,;62.71,-20.17,;64.04,-17.86,;62.7,-17.09,;61.38,-17.86,;60.03,-17.09,;60.04,-15.55,;61.37,-14.78,;62.7,-15.56,;64.03,-14.79,;64.04,-13.25,;65.37,-12.48,;66.7,-13.25,;68.04,-12.48,;68.04,-10.93,;69.36,-10.15,;70.69,-9.38,;66.7,-10.17,;66.7,-8.63,;65.36,-7.86,;64.02,-8.63,;64.45,-10.08,;63.26,-11.03,;62.11,-10.16,;61.65,-8.82,;62.8,-7.88,;59.91,-8.69,;58.46,-8.17,;58.19,-6.66,;56.74,-6.13,;56.47,-4.62,;55.03,-4.1,;53.84,-5.09,;52.4,-4.56,;54.11,-6.61,;55.56,-7.14,;61.18,-9.6,;61.62,-11.04,;62.4,-8.59,;65.37,-10.94,)| | ||
Structure |